IRIS - Res&Arch Institutional Research Information System - Research & Archive

CARLUCCIO, Erberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.876
EU - Europa 1.419
AS - Asia 730
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.872
IE - Irlanda 343
SG - Singapore 328
IT - Italia 250
SE - Svezia 226
UA - Ucraina 213
HK - Hong Kong 187
VN - Vietnam 92
CN - Cina 80
RU - Federazione Russa 80
FI - Finlandia 76
DE - Germania 71
FR - Francia 58
BE - Belgio 34
KR - Corea 25
GB - Regno Unito 22
CH - Svizzera 13
AT - Austria 11
NL - Olanda 9
PL - Polonia 6
UZ - Uzbekistan 5
EU - Europa 4
CA - Canada 3
JP - Giappone 3
AR - Argentina 2
BR - Brasile 2
CZ - Repubblica Ceca 2
TR - Turchia 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
GR - Grecia 1
IL - Israele 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.034
Salva come PNG Salva come JPEG
Città #
Chandler 426
Dublin 334
Singapore 274
Hong Kong 186
San Mateo 172
Boardman 133
Jacksonville 112
Santa Clara 109
Perugia 98
Dong Ket 92
Altamura 79
Medford 78
Princeton 78
Lawrence 64
Wilmington 60
Ann Arbor 58
Andover 56
Saint Petersburg 42
Beijing 38
Brussels 34
Helsinki 25
Seoul 20
Woodbridge 19
Munich 17
New York 17
Falls Church 14
Dallas 13
Des Moines 12
Los Angeles 12
Norwalk 12
Ashburn 11
Redwood City 11
Lappeenranta 10
Houston 8
San Paolo di Civitate 8
Shanghai 7
Frankfurt Am Main 6
Lausanne 6
Amsterdam 5
Florence 5
Guangzhou 5
Menlo Park 5
Milan 4
Nanning 4
Auburn Hills 3
Borgomanero 3
Peccioli 3
Bari 2
Bologna 2
Brno 2
Den Haag 2
Empoli 2
Esslingen am Neckar 2
Frankfurt am Main 2
Huskvarna 2
Izmir 2
Kagoya 2
Lucca 2
Moscow 2
Poznan 2
Quilmes 2
Redmond 2
Rome 2
Sanaa 2
São Paulo 2
Zhengzhou 2
Baku 1
Bear 1
Bolzano Vicentino 1
Bratislava 1
Cambridge 1
Cascina 1
Fairfield 1
Figline Valdarno 1
Fort Worth 1
Gangbuk-gu 1
Gualdo Tadino 1
Hackney 1
Haifa 1
Hamm 1
Islamabad 1
Lima 1
Ottawa 1
Philadelphia 1
Phnom Penh 1
Phoenix 1
Pisa 1
Riga 1
Rostock 1
Ruvo Di Puglia 1
San Benedetto Del Tronto 1
San Diego 1
San Francisco 1
Sant'agata De' Goti 1
Sassari 1
Seattle 1
Secaucus 1
Selargius 1
Shenyang 1
Springfield 1
Totale 2.860
Salva come PNG Salva come JPEG
Nome #
Atrial fibrillation in hypertension: predictors and outcome 107
Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy. 104
Relationship between contractile reserve and diastolic function in hibernating myocardium 86
Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. 85
Impact of metabolic syndrome on presentation and evolution of acute coronary syndromes 76
Apoptosi: come si può controllare la morte cellulare programmata e che benefici possiamo attenderci sul cuore? 75
Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure 72
Improved cardiovascular risk stratification by a simple ECG index in hypertension 72
Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction 70
Blood pressure variability: relation with sex and age. 70
Superior Prognostic Value of Right Ventricular Free Wall Compared to Global Longitudinal Strain in Patients With Heart Failure 69
Effects of Metabolic Syndrome on Pattern of Acute Coronary Syndromes 68
Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction 68
Long term follow up of acute coronary syndromes in patients with metabolic syndrome: differences between stemi vs nstemi 66
Advantages of deformation indices over systolic velocities in assessment of longitudinal systolic function in patients with heart failure and normal ejection fraction. 66
Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study 66
Elevated serum uric acid concentration at discharge confers additive prognostic value in elderly patients with acute heart failure 66
Arresto cardiaco ipocinetico ed ipereosinofilia: sindrome di Kounis o sindrome di Churg-Strauss? 64
Atrial Function in Patients Undergoing CRT REPLY 61
Left Atrial Reservoir Function and Outcome in Heart Failure With Reduced Ejection Fraction 61
Prognostic Value of Right Ventricular Dysfunction in Heart Failure With Reduced Ejection Fraction: Superiority of Longitudinal Strain Over Tricuspid Annular Plane Systolic Excursion 58
Effects of acute myocardial ischemia on QT dispersion by dipyridamole-stress echocardiography 58
[Dyslipidemia as cardiovascular and cerebrovascular risk factor: epidemiology and physiopathology] 57
Fattori che influenzano la presentazione elettrocardiografica e l'evoluzione clinica delle sindromi coronariche acute. 57
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction 57
C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. 55
Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction 55
Global longitudinal strain in heart failure with reduced ejection fraction: Prognostic relevance across disease severity as assessed by automated cluster analysis 55
La fibrinolisi nella terapia dell'infarto acuto del miocardio. Dai grandi trials alla pratica clinica: Risultati dell'U.O. di Cardiologia del Policlinico Monteluce di Perugia su 1151 pazienti consecutivi 53
Role of endothelial dysfunction in heart failure 53
Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: A multicenter cohort analysis 52
Gestione computerizzata del paziente sottoposto ad ecocardiografia con stress farmacologico 50
Microcirculation in hypertension 49
Valore prognostico del BNP nello scompenso cardiaco: importanza del raggiungimento di uno stato di euvolemia. 49
Valore prognostico dei livelli ematici di BNP nello scompenso cardiaco: stratificazione prognostica basata sulla combinazione tra riduzione percentuale e valore assoluto del BNP alla dimissione 49
Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony. 49
Exercise elicits dynamic changes in extravascular lung water and haemodynamic congestion in heart failure patients with preserved ejection fraction 49
Echo and BNP serial assessment in ambulatory heart failure care: Data on loop diuretic use and renal function 49
Correlazioni tra riserva contrattile e pattern di riempimento diastolico transmitralico nel miocardio ibernato. 48
Improvement of myocardial performance (Tei) index closely reflects intrinsic improvement of cardiac function: assessment in revascularized hibernating myocardium. 48
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran 48
Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients 48
EFFETTI DELLA TERAPIA CRONICA CON NITRODERIVATI NEI PAZIENTI CON SINDROMI CORONARICHE ACUTE 47
Pre-existing type 2 diabetes is associated with increased all-cause death independently of echocardiographic predictors of poor prognosis only in ischemic heart disease 47
Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: a double-blind, placebo controlled crossover stress echocardiographic study. 47
Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients 46
Long term follow-up of acute coronary syndrome in patients with Metabolic Syndrome. 45
The 'Echo Heart Failure Score': an echocardiographic risk prediction score of mortality in systolic heart failure. 45
Non-cardiac factors for prediction of response to cardiac resynchronization therapy: The value of baseline, and of serial changes, in red cell distribution width 44
Valore prognostico del BNP nello scompenso cardiaco: confronto fra variazione percentuale dei livelli ematici dall'ingresso alla predimissione e valore assoluto in predimissione 43
Improvement in TEI Index closely mirrors reversal of left ventricular dysfunction in chronic ischemic cardiomyopathy. 43
Relation between contractile riserve and diastolic function in hibernating myocardium. 42
Machine learning analysis of left ventricular function to characterize heart failure with preserved ejection fraction 42
Prognostic Value of Dynamic Changes in Pulmonary Congestion During Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction 42
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 41
Exercise-induced B-lines in heart failure with preserved ejection fraction occur along with diastolic function worsening 41
Burden of Ventricular Arrhythmias in CRT-D and ICD Recipients with Recovered Left Ventricular Ejection Fraction: the Additive Role of Speckle Tracking Echocardiography. 41
Usefulness of the severity and extent of wall motion abnormalities as prognostic markers of an adverse outcome after a first myocardial infarction treated with thrombolytic therapy 40
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 40
Combining echo and natriuretic peptides to guide heart failure care in the outpatient setting: A position paper 39
Commentary: Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: Physiology versus Empiricism 39
Left Atrial Strain in the Assessment of Diastolic Function in Heart Failure: A Machine Learning Approach 37
Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement 36
Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction 36
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 35
Reproducibility of echocardiographic assessment of 2D-derived longitudinal strain parameters in a population-based study (the STANISLAS Cohort study) 34
Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer 33
[The NEAT-HFpEF study] 32
Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF 32
Il miglioramento del Tei-index rispecchia strettamente il recupero della disfunzione ventricolare sinistra in pazienti con cardiomiopatia ischemica cronica. 31
Prognostic value of nt-probnp, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction 31
Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction 30
Management of heart failure in the new era: The role of scores 27
The left ventricle as a mechanical engine: From Leonardo da Vinci to the echocardiographic assessment of peak power output-to-left ventricular mass 25
Unraveling the relationship between serum uric acid levels and cardiovascular risk 24
Prognostic role of left ventricular ejection fraction in heart failure: Back to the future? 24
Effects of SGLT2 inhibitors on cardiac structure and function 24
Echocardiographic assessment of patient hemodynamics in heart failure 23
A strange case of Transthyretin Cardiac Amyloidosis in the Elderly: a diagnostic challenge 22
Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies 22
Left Atrio-ventricular Coupling Index: A Novel Diastolic Parameter to Refine Prognosis in Heart Failure 22
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 21
Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score 20
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction 17
Different right ventricular dysfunction and pulmonary coupling in acute heart failure according to the left ventricular ejection fraction 17
Non-invasive assessment of acute heart failure by Stevenson classification: Does echocardiographic examination recognize different phenotypes? 17
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study) 17
Vericiguat in heart failure with reduced ejection fraction: hope or solid reality? 16
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 15
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 15
Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer. 15
BLITZ-HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines 14
Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF 12
Right Heart Remodeling and Outcomes in Patients With Tricuspid Regurgitation: A Literature Review and Meta-Analysis 11
Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction 9
Managing hyperkalemia in patients with heart failure on guideline-directed medical therapy: challenges and opportunities 9
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 9
Eligibility for vericiguat in a real-world, contemporary heart failure population 9
Methods in diagnosing heart failure 9
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples 9
Totale 4.273
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.442
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 0 5 35 8 28 53 2 29
2020/2021600 6 27 31 32 159 58 37 15 61 29 41 104
2021/2022756 19 110 9 55 27 10 10 229 21 71 92 103
2022/20231.235 86 227 10 139 96 123 6 49 450 8 32 9
2023/2024541 20 84 26 22 4 2 157 4 55 19 64 84
2024/2025601 39 150 59 47 231 75 0 0 0 0 0 0
Totale 4.294